This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial.
The lancet. Diabetes & endocrinology, 13(11), 949-963
Citation
Wharton, Sean; Freitas, Paula; Hjelmesæth, Jøran; Kabisch, Maria; Kandler, Kristian; Lingvay, Ildiko; Quiroga, Maria; Rosenstock, Julio; Garvey, W Timothy. (2025). Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial.. The lancet. Diabetes & endocrinology, 13(11), 949-963. https://doi.org/10.1016/S2213-8587(25)00226-8